Publicaciones en las que colabora con Valentí Fuster (16)

2024

  1. β3-Adrenergic receptor overexpression in cardiomyocytes preconditions mitochondria to withstand ischemia–reperfusion injury

    Basic Research in Cardiology, Vol. 119, Núm. 5, pp. 773-794

2022

  1. Beta-3 adrenergic receptor overexpression reverses aortic stenosis–induced heart failure and restores balanced mitochondrial dynamics

    Basic Research in Cardiology, Vol. 117, Núm. 1

2017

  1. Neutrophil stunning by metoprolol reduces infarct size

    Nature Communications, Vol. 8

2016

  1. Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension

    Basic Research in Cardiology, Vol. 111, Núm. 4

2015

  1. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2

    Journal of the American College of Cardiology, Vol. 65, Núm. 14, pp. 1438-1450

  2. Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: New insights from a comprehensive translational study

    Journal of the American Heart Association, Vol. 4, Núm. 1

  3. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 35, Núm. 1, pp. 50-59

  4. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort the PESA (Progression of Early Subclinical Atherosclerosis) study

    Circulation, Vol. 131, Núm. 24, pp. 2104-2113

2014

  1. Intra-scar perfusion heterogeneity by cardiac magnetic resonance in a porcine model of non-reperfused myocardial infarction

    International Journal of Cardiology, Vol. 176, Núm. 3, pp. 1288-1289

  2. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)

    Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362

  3. Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial"

    Circulation

  4. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes

    Basic Research in Cardiology, Vol. 109, Núm. 4

2013

  1. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial

    Circulation, Vol. 128, Núm. 14, pp. 1495-1503

  2. Noninvasive monitoring of serial changes in pulmonary vascular resistance and acute vasodilator testing using cardiac magnetic resonance

    Journal of the American College of Cardiology, Vol. 62, Núm. 17, pp. 1621-1631

2012

  1. New index alpha improves detection of pulmonary hypertension in comparison with other cardiac magnetic resonance indices

    International Journal of Cardiology, Vol. 161, Núm. 1, pp. 25-30

2011

  1. Apical right ventricular dysfunction in patients with pulmonary hypertension demonstrated with magnetic resonance

    Heart, Vol. 97, Núm. 15, pp. 1250-1256